They are the most frequently reported adverse events across every clinical trial conducted to date
- Formulated with patented ingredient for melanin inhibition and breakdown
BPC-157 (body protection compound), is an endogenous, stable pentadecapeptide 15 amino acids first derived from gastric juices
Canadian Considerations: Access and Regulations Understanding the regulatory landscape helps Canadian researchers and biohackers navigate BPC-157 access appropriately
For each included study, data was extracted on study design, baseline population characteristics, intervention details (type and dose of GLP-1 receptor agonists), comparator, mean follow-up duration and reported cardiovascular outcomes
The animals were kept in a controlled environment with stable temperature and humidity under a 12-hour light/dark cycle